Import Bacopa Extract Upto 50% Bacoside — Buy in Bulk from Supplier in India

CSV Pharmaceuticals Pvt. Ltd. offers Bacopa Extract standardized to contain up to 50% Bacoside, a concentrated phytochemical derived from Bacopa monnieri, a perennial herb native to wetland environments across India. The extract is produced from aerial parts of the plant, with the bacoside fraction comprising a mixture of bacoside A, bacoside B, and related triterpenoid saponins that constitute the primary bioactive marker compounds. The supplier specifies a natural extraction process, though exact solvent and method details are not stated in the listing and should be confirmed directly.

Bacopa monnieri has been documented in traditional Ayurvedic texts for centuries, with modern pharmacological interest focused on its adaptogenic and nootropic properties. The 50% bacoside specification represents a mid-to-high concentration grade suitable for formulated dietary supplements rather than raw botanical material. Standard industry grades range from 20% to 80% bacoside content, with higher concentrations typically commanding premium pricing due to additional purification steps. The extract is hygroscopic in powdered form and requires controlled storage conditions to prevent degradation of the saponin fraction.

Primary buyers include nutraceutical manufacturers, functional food formulators, and contract supplement producers serving markets in North America, Europe, and Southeast Asia. Typical applications encompass capsule and tablet formulations, powdered drink mixes, and liquid tinctures where cognitive health positioning is desired. The listing indicates bulk supply availability without stating minimum order quantities, packaging formats, or lead times. Buyers should confirm with CSV Pharmaceuticals whether the material is offered as a free-flowing powder, granular form, or pre-milled specification, as these physical attributes affect downstream processing and blending operations.

CSV Pharmaceuticals Pvt. Ltd. is an India-registered pharmaceutical and herbal extract supplier operating within the country's well-established botanical extraction sector. The supplier carries an imported tier designation and a harbor trust tier, which indicates a baseline verification status on the platform without premium vetting. Notably, the response rate is recorded at 0.00% with zero average response hours, suggesting either a new listing, dormant account, or technical tracking issue. Buyers should treat initial outreach as unvalidated and plan for potential delays in quotation or sample provision.

The company profile does not disclose manufacturing facility details, GMP certification status, organic accreditation, or specific analytical capabilities such as HPLC or GC-MS testing. No client references, export history, or annual turnover figures are provided. The listing positions CSV Pharmaceuticals as a source for standardized Bacopa Extract, but buyers must independently verify production scale, batch consistency, and whether extraction is conducted in-house or through contracted third parties. Due diligence should include requesting a current Certificate of Analysis, botanical raw material traceability documentation, and evidence of compliance with destination market regulations such as USP-NF, EP, or food supplement GMP.